Donor Stem Cell Transplant in Treating Patients With Relapsed Hematologic Cancer
Conditions: Leukemia; Lymphoma; Multiple Myeloma; Plasma Cell Neoplasm; Myelodysplastic Syndromes; Myeloproliferative Neoplasms
Interventions: Biological: anti-thymocyte globulin; Biological: G-CSF; Drug: busulfan; Drug: fludarabine phosphate; Drug: methotrexate; Drug: mycophenolate mofetil; Drug: tacrolimus; Procedure: allogeneic cell transplantation; Drug: allopurinol
Sponsors: Alliance for Clinical Trials in Oncology; National Cancer Institute (NCI)
Completed - verified June 2016
Interventions: Biological: anti-thymocyte globulin; Biological: G-CSF; Drug: busulfan; Drug: fludarabine phosphate; Drug: methotrexate; Drug: mycophenolate mofetil; Drug: tacrolimus; Procedure: allogeneic cell transplantation; Drug: allopurinol
Sponsors: Alliance for Clinical Trials in Oncology; National Cancer Institute (NCI)
Completed - verified June 2016